(Q40068313)

17 September 2017

Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin (English)

1 reference

17 September 2017

1 reference

10

Otto C Boerman

1 reference

17 September 2017

5

Wim J G Oyen

1 reference

17 September 2017

1

Peter Laverman

1 reference

17 September 2017

7

Mark R Hellmich

1 reference

17 September 2017

Susan Roosenburg

2

1 reference

17 September 2017

Martin Gotthardt

3

1 reference

17 September 2017

Jeseong Park

4

1 reference

17 September 2017

Marion de Jong

6

1 reference

17 September 2017

Floris P J T Rutjes

8

1 reference

17 September 2017

Floris L van Delft

9

1 reference

17 September 2017

language of work or name

1 reference

13 October 2007

1 reference

17 September 2017

7

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

17 September 2017

35

1 reference

17 September 2017

2

1 reference

17 September 2017

386-392

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-007-0604-1

17 September 2017

0 references

cites work

Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK2) receptor splice variant

1 reference

12 December 2020

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

1 reference

12 December 2020

Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors

1 reference

12 December 2020

Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.

1 reference

12 December 2020

CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.

1 reference

12 December 2020

Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located?

1 reference

12 December 2020

Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo

1 reference

12 December 2020

Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth

1 reference

12 December 2020

Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors

1 reference

12 December 2020

Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma

1 reference

12 December 2020

Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours

1 reference

12 December 2020

Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human

1 reference

12 December 2020

Characterization of the CCK-C (cancer) receptor in human pancreatic cancer.

1 reference

12 December 2020

Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1 alpha expression and tumor growth

1 reference

12 December 2020

An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus

1 reference

12 December 2020

Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors

1 reference

12 December 2020

Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.

1 reference

12 December 2020

Characterization of the CCK-B/gastrin-like receptor in human colon cancer

1 reference

12 December 2020

10.1007/S00259-007-0604-1

Identifiers

DOI

1 reference

17 September 2017

1 reference